Search
for
Sort by
Research 361–390 of 1000+
- Improving selective androgen receptor modulator discovery and preclinical evaluation
- Human epithelial hair follicle stem cells and their progeny: Current state of knowledge, the widening gap in translational research and future challenges
- The Basic Science of Hair Biology
- Trichoscopy Tips
- Osteopontin Gene is Expressed in the Dermal Papilla of Pelage Follicles in a Hair-Cycle-Dependent Manner
- Hair camouflage: A comprehensive review
- Dermatologic Reactions to Targeted Therapy
- Hair Growth Promoting Effect of <i>Dicerocaryum senecioides</i> Phytochemicals
- The Biology of Hair Growth
- Hair in health and disease: an introduction
- Regulation of the human hair cycle
- Development of Stratum Corneum Lipid Liposomes for Topical Drug Delivery
- Lipid nanocarriers as innovative strategies for hair regrowth
- Subject Index
- Hair Biology and Nutritional Influences
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Role of Trichoscopy in Children's Scalp and Hair Disorders
- Venous thromboembolism and women's health
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Hair Loss in Men and Women
- <i>Curcuma aeruginosa</i>, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study
- Nurses' Drug Alert
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Clinical Management in Psychodermatology
- Abstracts Pt.30
- Cutaneous signals of immune system disease
- Development of MALDI-TOF-MS and MALDI-MSI methods for hair analysis and evaluation of cosmetic treatments
- Hair Today
- Controversies in off‐label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy